Gefarnate

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Gefarnate
Skeletal formula
Space-filling model
Clinical data
AHFS/Drugs.com International Drug Names
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
ECHA InfoCard 100.000.111
Chemical and physical data
Formula C27H44O2
Molar mass 400.637 g/mol
3D model (JSmol)
 NYesY (what is this?)  (verify)

Gefarnate is a drug used for the treatment of gastric ulcers.[1]

It also has been proposed for use in the treatment of dry eye syndrome.[2][3]

References[edit]

  1. ^ Ohta Y, Kobayashi T, Imai Y, Inui K, Yoshino J, Nakazawa S (August 2005). "Effect of gefarnate on acute gastric mucosal lesion progression in rats treated with compound 48/80, a mast cell degranulator, in comparison with that of teprenone". Biol. Pharm. Bull. 28 (8): 1424–30. PMID 16079487. doi:10.1248/bpb.28.1424. 
  2. ^ Peral A, Domínguez-Godínez CO, Carracedo G, Pintor J (April 2008). "Therapeutic targets in dry eye syndrome". Drug News Perspect. 21 (3): 166–76. PMID 18560615. 
  3. ^ Gipson IK, Hori Y, Argüeso P (April 2004). "Character of ocular surface mucins and their alteration in dry eye disease". Ocul Surf. 2 (2): 131–48. PMID 17216084. doi:10.1016/s1542-0124(12)70149-0. [permanent dead link]